Similar articles

• Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.

  Law LS, Lo EA, Yeoh SF. Law LS, et al. Am J Ophthalmol. 2021 Feb;222:399-400. doi: 10.1016/j.ajo.2020.09.016. Epub 2020 Nov 20. Am J Ophthalmol. 2021. PMID: 33223050 No abstract available.
• Hydroxychloroquine retinopathy: screening needed to prevent blindness.

  Hodson TJ. Hodson TJ. Med J Aust. 2011 Jan 3;194(1):55. doi: 10.5694/j.1326-5377.2011.tb04161.x. Med J Aust. 2011. PMID: 21449879 No abstract available.
• How to set up a Hydroxychloroquine Retinopathy Screening Service.

  Zaidi FH, Rennie CA, Drinkwater AK, Sahu D, Akyol E, Lotery AJ. Zaidi FH, et al. Eye (Lond). 2019 Nov;33(11):1679-1682. doi: 10.1038/s41433-019-0418-y. Epub 2019 Apr 26. Eye (Lond). 2019. PMID: 31028287 Free PMC article. No abstract available.
• Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?

  Aduriz-Lorenzo PM, Aduriz-Llaneza P, Araiz-Iribarren J, Khamashta MA. Aduriz-Lorenzo PM, et al. Lupus. 2020 Jun;29(7):671-675. doi: 10.1177/0961203320919499. Epub 2020 Apr 21. Lupus. 2020. PMID: 32316844 Review.
• Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.

  Browning DJ, Yokogawa N, Greenberg PB, Perlman E. Browning DJ, et al. Am J Ophthalmol. 2020 Nov;219:101-106. doi: 10.1016/j.ajo.2020.06.030. Epub 2020 Jun 28. Am J Ophthalmol. 2020. PMID: 32610049 Review.